First Time Loading...

Kezar Life Sciences Inc
NASDAQ:KZR

Watchlist Manager
Kezar Life Sciences Inc Logo
Kezar Life Sciences Inc
NASDAQ:KZR
Watchlist
Price: 0.7876 USD -3.55%
Updated: Apr 19, 2024

Intrinsic Value

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco a... [ Read More ]

The intrinsic value of one KZR stock under the Base Case scenario is 1.0639 USD. Compared to the current market price of 0.7876 USD, Kezar Life Sciences Inc is Undervalued by 26%.

Key Points:
KZR Intrinsic Value
Base Case
1.0639 USD
Undervaluation 26%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Kezar Life Sciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling KZR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Kezar Life Sciences Inc

Provide an overview of the primary business activities
of Kezar Life Sciences Inc.

What unique competitive advantages
does Kezar Life Sciences Inc hold over its rivals?

What risks and challenges
does Kezar Life Sciences Inc face in the near future?

Has there been any significant insider trading activity
in Kezar Life Sciences Inc recently?

Summarize the latest earnings call
of Kezar Life Sciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kezar Life Sciences Inc.

Provide P/S
for Kezar Life Sciences Inc.

Provide P/E
for Kezar Life Sciences Inc.

Provide P/OCF
for Kezar Life Sciences Inc.

Provide P/FCFE
for Kezar Life Sciences Inc.

Provide P/B
for Kezar Life Sciences Inc.

Provide EV/S
for Kezar Life Sciences Inc.

Provide EV/GP
for Kezar Life Sciences Inc.

Provide EV/EBITDA
for Kezar Life Sciences Inc.

Provide EV/EBIT
for Kezar Life Sciences Inc.

Provide EV/OCF
for Kezar Life Sciences Inc.

Provide EV/FCFF
for Kezar Life Sciences Inc.

Provide EV/IC
for Kezar Life Sciences Inc.

Show me price targets
for Kezar Life Sciences Inc made by professional analysts.

What are the Revenue projections
for Kezar Life Sciences Inc?

How accurate were the past Revenue estimates
for Kezar Life Sciences Inc?

What are the Net Income projections
for Kezar Life Sciences Inc?

How accurate were the past Net Income estimates
for Kezar Life Sciences Inc?

What are the EPS projections
for Kezar Life Sciences Inc?

How accurate were the past EPS estimates
for Kezar Life Sciences Inc?

What are the EBIT projections
for Kezar Life Sciences Inc?

How accurate were the past EBIT estimates
for Kezar Life Sciences Inc?

Compare the revenue forecasts
for Kezar Life Sciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kezar Life Sciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kezar Life Sciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kezar Life Sciences Inc compared to its peers.

Compare the P/E ratios
of Kezar Life Sciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Kezar Life Sciences Inc with its peers.

Analyze the financial leverage
of Kezar Life Sciences Inc compared to its main competitors.

Show all profitability ratios
for Kezar Life Sciences Inc.

Provide ROE
for Kezar Life Sciences Inc.

Provide ROA
for Kezar Life Sciences Inc.

Provide ROIC
for Kezar Life Sciences Inc.

Provide ROCE
for Kezar Life Sciences Inc.

Provide Gross Margin
for Kezar Life Sciences Inc.

Provide Operating Margin
for Kezar Life Sciences Inc.

Provide Net Margin
for Kezar Life Sciences Inc.

Provide FCF Margin
for Kezar Life Sciences Inc.

Show all solvency ratios
for Kezar Life Sciences Inc.

Provide D/E Ratio
for Kezar Life Sciences Inc.

Provide D/A Ratio
for Kezar Life Sciences Inc.

Provide Interest Coverage Ratio
for Kezar Life Sciences Inc.

Provide Altman Z-Score Ratio
for Kezar Life Sciences Inc.

Provide Quick Ratio
for Kezar Life Sciences Inc.

Provide Current Ratio
for Kezar Life Sciences Inc.

Provide Cash Ratio
for Kezar Life Sciences Inc.

What is the historical Revenue growth
over the last 5 years for Kezar Life Sciences Inc?

What is the historical Net Income growth
over the last 5 years for Kezar Life Sciences Inc?

What is the current Free Cash Flow
of Kezar Life Sciences Inc?

Financials

Balance Sheet Decomposition
Kezar Life Sciences Inc

Current Assets 207m
Cash & Short-Term Investments 201.4m
Receivables 2.3m
Other Current Assets 3.3m
Non-Current Assets 14.3m
PP&E 8.7m
Other Non-Current Assets 5.6m
Current Liabilities 17.7m
Accounts Payable 8.3m
Accrued Liabilities 9.5m
Non-Current Liabilities 15.9m
Long-Term Debt 10.1m
Other Non-Current Liabilities 5.9m
Efficiency

Earnings Waterfall
Kezar Life Sciences Inc

Revenue
7m USD
Operating Expenses
-112.2m USD
Operating Income
-105.2m USD
Other Expenses
3.4m USD
Net Income
-101.9m USD

Free Cash Flow Analysis
Kezar Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

KZR Profitability Score
Profitability Due Diligence

Kezar Life Sciences Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

16/100
Profitability
Score

Kezar Life Sciences Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

KZR Solvency Score
Solvency Due Diligence

Kezar Life Sciences Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
55/100
Solvency
Score

Kezar Life Sciences Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KZR Price Targets Summary
Kezar Life Sciences Inc

There are no price targets for KZR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

KZR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

KZR Price
Kezar Life Sciences Inc

1M 1M
-10%
6M 6M
-18%
1Y 1Y
-68%
3Y 3Y
-86%
5Y 5Y
-96%
10Y 10Y
-96%
Annual Price Range
0.7876
52w Low
0.72
52w High
3.06
Price Metrics
Average Annual Return 27.39%
Standard Deviation of Annual Returns 127.51%
Max Drawdown -97%
Shares Statistics
Market Capitalization 57.3m USD
Shares Outstanding 72 801 400
Percentage of Shares Shorted 5.07%

KZR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Kezar Life Sciences Inc Logo
Kezar Life Sciences Inc

Country

United States of America

Industry

Biotechnology

Market Cap

57.3m USD

Dividend Yield

0%

Description

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. The company is headquartered in South San Francisco, California and currently employs 56 full-time employees. The company went IPO on 2018-06-21. The firm's product portfolio includes KZR-616 and KZR-261. The KZR-616 is a selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib trial in patients with systemic lupus erythematosus (SLE). KZR-261 is being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. The firm has two drug development programs that harness different master regulators of cellular function, which include the immunoproteasome and the Sec61 translocon. The Company’s principal operations are in South San Francisco, California.

Contact

CALIFORNIA
South San Francisco
4000 Shoreline Ct Ste 300
+16508225600.0
http://kezarlifesciences.com/

IPO

2018-06-21

Employees

56

Officers

Co-Founder, CEO & Director
Dr. Christopher J. Kirk Ph.D.
Co-Founder & Director
Mr. John Franklin Fowler
Co-Founder
Dr. Jack Taunton Ph.D.
CFO & Secretary
Mr. Marc L. Belsky
Vice President of Investor Relations & External Affairs
Ms. Gitanjali Jain
Chief Legal Officer
Mr. Mark Schiller
Show More
Senior Vice President of Research & Drug Discovery
Dr. Neel K. Anand Ph.D.
Chief Business Officer & Head of Strategy
Dr. Nick Mordwinkin Ph.D., Pharm.D.
Senior Vice President of Clinical Development
Mr. Zung To
VP & Corporate Controller
Ms. Pattie Chiang
Show Less

See Also

Discover More
What is the Intrinsic Value of one KZR stock?

The intrinsic value of one KZR stock under the Base Case scenario is 1.0639 USD.

Is KZR stock undervalued or overvalued?

Compared to the current market price of 0.7876 USD, Kezar Life Sciences Inc is Undervalued by 26%.